Neural Regeneration Research, 2014 · DOI: 10.4103/1673-5374.143423 · Published: October 1, 2014
Spinal cord injury (SCI) has three phases: acute, secondary and chronic. The outcomes of SCI are mainly influenced by the secondary phase. SCI causes inflammatory responses through the activation of innate immune responses that contribute to secondary injury. Macrophages in the central nervous system (CNS) derived from blood monocytes and resident microglia, are pervasive in the injured spinal cord and change their phenotypes and functions in response to signals in the lesion environment. This review discusses the behavior and influence of microglia/macrophages during secondary damage from the pathophysiology of spinal cord injury, and how microglia and macrophages affect secondary injury, and the subsets of microglia/macrophages and their interrelationships in secondary injury mechanisms.
Modulating macrophage function to mitigate secondary damage after SCI could lead to new therapeutic approaches.
Understanding the balance between pro-inflammatory and anti-inflammatory responses is crucial for promoting recovery of motor function.
Targeting specific macrophage subsets based on their activities (inflammation, phagocytosis, regeneration) may optimize treatment strategies.